Effectiveness of Cervical Cancer Screening Over Cervical Cancer Mortality Among Japanese Women

    loading  Checking for direct PDF access through Ovid



Various studies have revealed that cervical cancer (CC) screening significantly reduces both CC incidence and mortality in developed countries. Although Japan introduced a nationwide government funded annual CC screening for the women aged 30+ in 1982, the effectiveness of CC screening on CC mortality has not yet been evaluated by any prospective cohort study. Therefore, the present study evaluated the association of CC mortality with self-reported CC screening and some other factors by a nationwide cohort study.


Baseline survey of the Japan Collaborative Cohort Study for the enrollment of subjects was completed during 1988–90 and followed until 2003. This study only analyzed 63 541 women, aged 30–79 years, who were free from any cancer history at enrollment.


During the follow-up period, 38 CC deaths were identified. The mean age at mortality was 67.0 years, with a mortality rate of 4.2 per 100 000 person-years. Participation rate in CC screening was 46.9%. Age-adjusted Cox model indicated significantly lower CC mortality [hazard ratio (HR)=0.30, 95% confidence interval (CI)=0.12–0.74] due to CC screening. Protectiveness remained almost the same (HR=0.30, 95% CI=0.12–0.76) when adjusted for age, body mass index and number of deliveries. The results also revealed that CC screening could reduce at least 50% of CC deaths even after excluding the effect of possible self-selection bias.


CC screening in Japan may reduce CC mortality significantly for women aged 30–79 years. However, further studies with more CC deaths and increased statistical power are needed to validate the findings.

Related Topics

    loading  Loading Related Articles